Jaka jest cena za NeuroMetrix, Inc. (NURO)

Cena za NeuroMetrix, Inc. (NURO) wynosi $4.58

Jaka jest kapitalizacja rynkowa dla NeuroMetrix, Inc. (NURO)

Kapitalizacja rynkowa dla NeuroMetrix, Inc. (NURO) wynosi $6.98M

NeuroMetrix, Inc. (NURO) Dywidendy

NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.

Rok	Dywidenda (skorygowana o podziały akcji)	Zmień
2026 (TTM)	$13,824.00	0.00%
2007	$13,824.00	0.00%

Rok

Dywidenda (skorygowana o podziały akcji)

Zmień

2026 (TTM)

$13,824.00

0.00%

2007

$13,824.00

0.00%

Rok	Dywidenda	Zmień
2026 (TTM)	$0.15	0.00%
2007	$0.15	0.00%

Rok

Dywidenda

Zmień

2026 (TTM)

$0.15

0.00%

2007

$0.15

0.00%

Firma	Liczba wypłat dywidend	Kraj
Abbott Laboratories ABT.US	173.00%	US
Stryker Corporation SYK.US	85.00%	US
Medtronic plc MDT.US	178.00%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

Firma

Liczba wypłat dywidend

Kraj